BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18272374)

  • 1. Association study of the GAB2 gene with the risk of developing Alzheimer's disease.
    Chapuis J; Hannequin D; Pasquier F; Bentham P; Brice A; Leber I; Frebourg T; Deleuze JF; Cousin E; Thaker U; Amouyel P; Mann D; Lendon C; Campion D; Lambert JC
    Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis.
    Ikram MA; Liu F; Oostra BA; Hofman A; van Duijn CM; Breteler MM
    Biol Psychiatry; 2009 Jun; 65(11):995-9. PubMed ID: 19118819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease.
    Nacmias B; Tedde A; Bagnoli S; Cellini E; Guarnieri BM; Piacentini S; Sorbi S
    J Alzheimers Dis; 2009; 16(3):513-5. PubMed ID: 19276544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese.
    Bian JT; Zhang JW; Zhang ZX; Zhao HL
    Neurosci Lett; 2005 Oct; 387(1):11-6. PubMed ID: 16054753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
    Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
    J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein.
    Smach MA; Charfeddine B; Othman LB; Lammouchi T; Ltaief A; Nafati S; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2010 Mar; 472(2):139-42. PubMed ID: 20138124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism.
    Rodríguez-Manotas M; Amorín-Díaz M; Cañizares-Hernández F; Ruíz-Espejo F; Martínez-Vidal S; González-Sarmiento R; Martínez-Hernández P; Cabezas-Herrera J
    Brain Res; 2007 Sep; 1170():119-28. PubMed ID: 17719017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE dependent-association of PPAR-γ genetic variants with Alzheimer's disease risk.
    Combarros O; Rodríguez-Rodríguez E; Mateo I; Vázquez-Higuera JL; Infante J; Berciano J; Sánchez-Juan P
    Neurobiol Aging; 2011 Mar; 32(3):547.e1-6. PubMed ID: 19660836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women.
    Fontalba A; Gutiérrez O; Llorca J; Mateo I; Berciano J; Fernández-Luna JL; Combarros O
    Dement Geriatr Cogn Disord; 2008; 26(3):247-50. PubMed ID: 18841008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.
    Pesaresi M; Batelli S; Prato F; Polito L; Lovati C; Scarpini E; Quadri P; Mariani C; Albani D; Forloni G
    Neurobiol Dis; 2007 Mar; 25(3):609-13. PubMed ID: 17174555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease.
    Kharrazi H; Vaisi-Raygani A; Rahimi Z; Tavilani H; Aminian M; Pourmotabbed T
    Clin Biochem; 2008 Aug; 41(12):932-6. PubMed ID: 18505684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease.
    Traykov L; Bayle AC; Latour F; Lenoir H; Seux ML; Hanon O; Péquignot R; Bert P; Moulin F; Cantegreil I; Wenisch E; Batouche F; Mehrabian S; Rotrou Jd; Rigaud AS
    J Neurol Sci; 2007 Jun; 257(1-2):280-3. PubMed ID: 17337010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease.
    Tedde A; Bagnoli S; Piaceri I; Lucenteforte E; Bessi V; Bracco L; Mugelli A; Sorbi S; Nacmias B
    Neurosci Lett; 2010 Jun; 477(3):121-3. PubMed ID: 20430066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association analysis of the paraoxonase-1 gene with Alzheimer's disease.
    Cellini E; Tedde A; Bagnoli S; Nacmias B; Piacentini S; Bessi V; Bracco L; Sorbi S
    Neurosci Lett; 2006 Nov; 408(3):199-202. PubMed ID: 16996683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
    Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
    Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E promoter polymorphisms and risk of Alzheimer's disease: evidence from meta-analysis.
    Xin XY; Ding JQ; Chen SD
    J Alzheimers Dis; 2010; 19(4):1283-94. PubMed ID: 20061606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter polymorphism in fibroblast growth factor 1 gene increases risk of definite Alzheimer's disease.
    Yamagata H; Chen Y; Akatsu H; Kamino K; Ito J; Yokoyama S; Yamamoto T; Kosaka K; Miki T; Kondo I
    Biochem Biophys Res Commun; 2004 Aug; 321(2):320-3. PubMed ID: 15358178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GAB2 gene does not modify the risk of Alzheimer's disease in Spanish APOE 4 carriers.
    Ramirez-Lorca R; Boada M; Saez ME; Hernandez I; Mauleon A; Rosende-Roca M; Martinez-Lage P; Gutierrez M; Real LM; Lopez-Arrieta J; Gayan J; Antunez C; Gonzalez-Perez A; Tarraga L; Ruiz A
    J Nutr Health Aging; 2009 Mar; 13(3):214-9. PubMed ID: 19262956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.